Financials Reata Pharmaceuticals, Inc. Börse Stuttgart
Equities
2R3
US75615P1030
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.63% | +373.53% |
2023 | Reata Pharmaceuticals, Inc. Announces Management Changes | CI |
2023 | Biogen Closes Reata Pharmaceuticals Acquisition | MT |
Income Statement Evolution (Annual data)
Fiscal Period: |
---|
Balance Sheet Analysis
Fiscal Period: |
---|
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+1.98% | 22.58B | |
-14.29% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- RETA Stock
- 2R3 Stock
- Financials Reata Pharmaceuticals, Inc.